StonvexLoading…
StonvexStonvexStonvexCore line items from AMST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $285.68K | $202.35K | $94.30K | $54.70K |
Operating Income | $-2.09M | $-1.41M | $-662.12K | $-2.75M |
Net Income | $-2.05M | $-732.55K | $-642.27K | $-2.69M |
EPS (Diluted) | $-0.45 | $-0.30 | $-0.14 | $-0.85 |
Total Assets | $1.49M | $2.00M | $2.60M | $3.81M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $640.71K | $1.17M | $1.83M | $2.86M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 4.74M | 4.57M | 4.57M | 4.57M |